Zinc and alpha-fetoprotein in amniotic fluid from early pregnancies with fetal malformations. 1985

R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori

Zinc and alpha-fetoprotein concentrations were quantitated in second-trimester amniotic fluid from 111 normal pregnancies and 29 pregnancies with various fetal malformations. The zinc level varied between 0.3 and 4.0 mumol/L (median 1.3) in the normal samples and between 1.8 and 17.9 mumol/L (median 5.0) in cases with malformations. The level was above 2.5 times the normal median in 23 of the 29 (79%) gestations with the malformations. Amniotic fluid zinc and alpha-fetoprotein levels showed a positive correlation (r = 0.78), and the alpha-fetoprotein level was elevated in all gestations with fetal disorders and elevated zinc levels, as well as in five of the six cases with fetal defects but normal zinc concentrations. The elevation of zinc was more marked than that of alpha-fetoprotein in three cases of fetal malformations. Five samples were false positive on alpha-fetoprotein assay but contained normal zinc levels. Removal of alpha-fetoprotein from amniotic fluid had no effect on the zinc concentration, indicating that zinc is not bound to amniotic fluid alpha-fetoprotein.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000013 Congenital Abnormalities Malformations of organs or body parts during development in utero. Birth Defects,Congenital Defects,Deformities,Fetal Anomalies,Fetal Malformations,Abnormalities, Congenital,Defects, Congenital,Abnormality, Congenital,Anomaly, Fetal,Birth Defect,Congenital Abnormality,Congenital Defect,Defect, Birth,Defect, Congenital,Deformity,Fetal Anomaly,Fetal Malformation,Malformation, Fetal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid

Related Publications

R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
November 1987, La Clinica terapeutica,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
April 1988, British journal of obstetrics and gynaecology,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
February 1975, Clinical genetics,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
August 1984, American journal of obstetrics and gynecology,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
March 1978, Lancet (London, England),
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
October 1980, Pediatrics,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
May 1974, American journal of obstetrics and gynecology,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
October 1989, Prenatal diagnosis,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
January 1976, Acta obstetricia et gynecologica Scandinavica,
R Laitinen, and H Jalanko, and K L Kolho, and H von Koskull, and E Vuori
January 1988, Fetal therapy,
Copied contents to your clipboard!